Cannabix Addresses Challenges with Marijuana Testing in the Workplace
September 13th, 2021
App, Exclusive, News, Top News, Top Story
Marijuana legalization is on the rise across the United States. While decriminalization is a noble cause, there are many unintended consequences that the government and private sector struggle to manage. One of the most significant challenges is detecting when someone is under the influence of marijuana. Cannabix Technologies Inc. (CSE: BLO) (OTC: BLOZF) is an innovative company actively developing solutions to address this growing problem.
Problems in the Workplace
There’s no doubt that marijuana use causes cognitive impairment. The adverse effects on attention, memory, and learning can last for days or weeks after the acute effects of “getting high” wear off. While low productivity is a concern for businesses, workplace safety is far more significant with life-or-death implications.
Quest Diagnostics, one of the largest drug testing laboratories in the country, recently reported that 4.4 percent of all U.S. workers tested positive for marijuana in 2020. Even worse, 2.2 percent of workers in sensitive industries—like truck driving, pilots, or nuclear power plant workers—tested positive for marijuana.
Commonly used urine drug tests cannot determine if individuals are under the influence at the test time, post-accident data suggests that marijuana may play a role in incidents that prompted a drug test. Pre-employment positivity was just 3.7 percent compared to post-accident positivity of 6.4 percent, pointing strongly toward an impact.
Quest Diagnostics also found that marijuana use was on the rise in states where the drug has been legalized for recreational use. With a growing number of states falling under that umbrella, employers need to find ways to discourage on-the-job marijuana use to prevent accidents and create a better and more productive workplace.
The Need for Real-time Tests
Most marijuana tests do not discern the recency of marijuana consumption and have virtually no correlation to impairment.
The need for real-time tests is evident in industries like long-haul trucking. Everyone agrees that truck drivers should never drive under the influence of marijuana, but a new federal clearinghouse and new regulations allowing hair follicle testing have gone too far. These laws could prevent truckers from using recreational marijuana during their own time. Since the clearinghouse went into effect, the industry has already lost nearly 50,000 drivers.
Long detection window makes urine tests less useful. Source: Cannabix Technologies Inc.
Fortunately, new technologies could open the door to real-time tests. In particular, breath analysis has the potential to detect recent marijuana use. Aerosol particles in exhaled breath are formed from respiratory tract lining fluid that only contains THC for a relatively short period of time (one to three hours), aligning with the peak impairment window.
In addition to more accurate readings, breath analysis is non-invasive and non-intrusive, leading to fewer privacy issues. Furthermore, the inexpensive tests don’t require any nurses or technicians, and they can be completed at the point of care rather than sent to a third-party lab. It’s a far better solution than intrusive and expensive urine or blood tests.
Investing in a Solution
Cannabix Technologies Inc. (CSE: BLO) (OTC: BLOZF) is quickly developing cannabis breathalyzer technologies that would be appropriate for work place and other settings. In addition to securing patents on its unique approaches, the company’s advanced prototypes are already in beta testing in real world situations.
THC Breath Analyzer prototype. Source: Cannabix Technologies Inc.
With a growing need among employers and law enforcement, the company could see a lot of growth if it successfully launches a product into the market.
Marijuana use has become a growing problem in the workplace. Unfortunately, most conventional marijuana testing methods like oral fluid or urine testing do not correlate well with peak impairment and can show detection of THC after several hours or days after use. Recreational cannabis users who are not “high” could experience a false positive, leading to unfair consequences. Fortunately, new technologies aim to improve accuracy and fairness.
Cannabix Technologies Inc. (CSE: BLO) (OTC: BLOZF) is developing THC breath analysis tools that could provide point-of-care solutions that detect marijuana use within a short period of time after consumption. The result is a solution that law enforcement and workplace officials could use to ensure safety and compliance.
For more information, visit the company’s website.
The above article is sponsored content. CannabisFN.com and CFN Media, have been hired to create awareness. Please follow the link below to view our full disclosure outlining our compensation: https://cannabisfn.com/legal-disclaimer/
This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.
Follow Us on Social Media
About CFN Media Group
CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.
Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.